NASDAQ
Kobayashi Pharmaceutical Co., Ltd. (KBYPF) has a price/sales ratio of 2.43x as of Friday, May 22, 2026. This represents a 30.61% decrease compared to its 12-month average of 3.51x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.